Page last updated: 2024-08-21

salicylaldehyde isonicotinoyl hydrazone and Acute Promyelocytic Leukemia

salicylaldehyde isonicotinoyl hydrazone has been researched along with Acute Promyelocytic Leukemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adamcová, M; Gersl, V; Hasková, P; Hroch, M; Kaiserová, H; Ponka, P; Popelová, O; Simůnek, T; Sterba, M1

Other Studies

1 other study(ies) available for salicylaldehyde isonicotinoyl hydrazone and Acute Promyelocytic Leukemia

ArticleYear
Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone.
    British journal of pharmacology, 2008, Volume: 155, Issue:1

    Topics: Aldehydes; Animals; Animals, Newborn; Antibiotics, Antineoplastic; Cell Proliferation; Cell Survival; Cytoprotection; Daunorubicin; Dose-Response Relationship, Drug; HL-60 Cells; Humans; Hydrazones; Iron Chelating Agents; Leukemia, Promyelocytic, Acute; Lipid Peroxidation; Malondialdehyde; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Wistar; Time Factors

2008